Hengrui Medicine (01276.HK): Sodium citrate blood filtration replacement solution approved for marketing.

China Finance News App, Jiangsu Hengrui Medicine (01276.HK) announced that recently, its subsidiary Fujian Shengdi Medicine Co., Ltd. received a notice from the National Medical Products Administration (referred to as "NMPA") approving the listing of the company's sodium citrate hemofiltration solution.